Chemical Management, Science and Research

WORLD SCALECRUDE TO OLEFINS

December 1, 2022

WORLD SCALECRUDE
The Crude-to-Chemicals project is designed for world-scale petrochemicals production to deliver a flexible, bankable, and sustainable free-market investment. Through strong cooperation with the customer, Honeywell UOP has developed a configuration that enables 100% net olefins
derived products.

Spotlight

Immunocore

Based in Abingdon (UK) and Philadelphia (USA) we're a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases. Our world-leading T cell receptor technology exploits the power of the body’s own immune system to find and kill diseased cells. We've established a robust technology platform which combines monoclonal T cell receptor (mTCR) targeting technology with an effector technology, anti-CD3 scFv, that catalyses the killing of the targeted diseased cells by the host’s own non-specific cytotoxic T cells. And we're developing a portfolio of products from the platform, called ImmTACs, for the treatment of cancer, chronic infectious disease and diabetes.

OTHER WHITEPAPERS
news image

Advanced Recycling: Seizing the Circular Plastics Opportunity

whitePaper | March 11, 2022

Our modern way of life would not be possible without plastics. However, better post-use management of plastic products is required, and we need to move to a circular economy for plastics that recognizes plastics as a resource or feedstock, not a waste.

Read More
news image

Oil & Gas Industry Buyer’s Guide to BS-Free Talent Solutions

whitePaper | July 13, 2022

When it comes to talent solutions, authenticity matters. If a provider isn’t challenging you as a buyer, if they’re not asking questions and having really open and frank discussions

Read More
news image

EH&S GUIDELINES FOR PEROXIDE FORMING CHEMICALS

whitePaper | August 11, 2022

This guide will help you manage your peroxide forming chemicals and outlines the procedures for the required stabilization of peroxide forming chemicals and destruction of peroxides prior to disposal.

Read More
news image

Carbon Capture, Transport, & Storage

whitePaper | February 24, 2022

The report “America’s Strategy to Secure the Supply Chain for a Robust Clean Energy Transition” lays out the challenges and opportunities faced by the United States in the energy supply chain as well as the federal government plans to address these challenges and opportunities.

Read More
news image

CHEMICAL (RE)ACTION

whitePaper | January 15, 2022

While sustainability has long been on the chemical industry agenda, the value paradigm is shifting fast.

Read More
news image

Addressing decarbonization at the grid edge

whitePaper | December 24, 2022

This whitepaper discusses decarbonization and how it affects consumers in the commercial and industrial (C&I) sector. It is based on expert insight and market interviews conducted during summer of 2020 and reflects Siemens’ and Delta-EE’s common view on the topic.

Read More

Spotlight

Immunocore

Based in Abingdon (UK) and Philadelphia (USA) we're a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases. Our world-leading T cell receptor technology exploits the power of the body’s own immune system to find and kill diseased cells. We've established a robust technology platform which combines monoclonal T cell receptor (mTCR) targeting technology with an effector technology, anti-CD3 scFv, that catalyses the killing of the targeted diseased cells by the host’s own non-specific cytotoxic T cells. And we're developing a portfolio of products from the platform, called ImmTACs, for the treatment of cancer, chronic infectious disease and diabetes.

Events